Lumos Diagnostics provides development and manufacturing services for rapid point-of-care (POC) products, customized for our partners’ needs. Lumos combines a unique mix of assay and engineering capability, with proven reader and cloud technologies to create disruptive, connected POC solutions. Since acquiring Kestrel BioSciences and incorporating their 30 years’ experience in assay development, Lumos is the only POC company offering a fully tailored solution to achieve business and user needs.